Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain

Author:

Xu Hao-Ming1ORCID,Huang Hong-Li1ORCID,Zhou You-Lian1ORCID,Zhao Hai-Lan1ORCID,Xu Jing1ORCID,Shou Di-Wen1ORCID,Liu Yan-Di1ORCID,Zhou Yong-Jian1ORCID,Nie Yu-Qiang1ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Guangzhou Digestive Disease Center, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China

Abstract

Gut dysbacteriosis is closely related to various intestinal and extraintestinal diseases. Fecal microbiota transplantation (FMT) is a biological therapy that entails transferring the gut microbiota from healthy individuals to patients in order to reconstruct the intestinal microflora in the latter. It has been proved to be an effective treatment for recurrent Clostridium difficile infection. Studies show that the gut microbiota plays an important role in the pathophysiology of neurological and psychiatric disorders through the microbiota-gut-brain axis. Therefore, reconstruction of the healthy gut microbiota is a promising new strategy for treating cerebral diseases. We have reviewed the latest research on the role of gut microbiota in different nervous system diseases as well as FMT in the context of its application in neurological, psychiatric, and other nervous system-related diseases (Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, epilepsy, autism spectrum disorder, bipolar disorder, hepatic encephalopathy, neuropathic pain, etc.).

Funder

Innovative Clinical Technique of Guangzhou

Publisher

Hindawi Limited

Subject

Gastroenterology,Hepatology

Reference189 articles.

1. Part 1: the human gut microbiome in health and disease;M. J. Bull;Integrative Medicine: A Clinician's Journal,2014

2. The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes;C. M. Rath;Current Opinion in Microbiology,2012

3. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease;S. Hasegawa;PLoS One,2015

4. Colonic bacterial composition in Parkinson's disease;A. Keshavarzian;Movement Disorders,2015

5. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort;P. Liu;Brain, Behavior, and Immunity,2019

Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3